As of November 2024 Xvivo Perfusion AB has a market cap of NZ$2.15 Billion. This makes Xvivo Perfusion AB the world's 5123th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.